We aim to contribute to the implementation of preventive medicine through molecular understanding of disease pathogenesis and early diagnostic biomarker research and development, and to lead the research of nutrigenomic solutions. Human blood contains non-cellular DNA shed from cancer cells, which is a clue for disease analysis. Our lab is focusing on the study of mutations and Metallization in non-cellular DNA based on molecular diagnostic technology of fluid biopsy technique to develop minimally invasive disease early diagnosis biomarkers. In the future, we will contribute to the implementation of preventive medicine through molecular understanding of disease pathogenesis and early diagnostic biomarker research and development, and lead the research on nutrigenomics solutions.